Growth Metrics

Merck (MRK) Enterprise Value Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 18.19%
Dec 31, 2025 -3.40%
Sep 30, 2025 -17.54%
Jun 30, 2025 5.24%
Mar 31, 2025 -1.13%
Dec 31, 2024 -19.32%
Sep 30, 2024 -13.48%
Jun 30, 2024 -10.00%
Mar 31, 2024 6.89%
Dec 31, 2023 4.03%
Sep 30, 2023 -6.24%
Jun 30, 2023 16.83%
Mar 31, 2023 -12.03%
Dec 31, 2022 -8.22%
Sep 30, 2022 -12.13%
Jun 30, 2022 -12.81%
Mar 31, 2022 -0.73%
Dec 31, 2021 2.60%
Sep 30, 2021 0.35%
Jun 30, 2021 -4.85%
Mar 31, 2021 1.07%
Dec 31, 2020 1.23%
Sep 30, 2020 23.19%
Jun 30, 2020 7.32%
Mar 31, 2020 20.10%
Dec 31, 2019 9.82%
Sep 30, 2019 14.87%
Jun 30, 2019 15.83%
Mar 31, 2019 12.30%
Dec 31, 2018 13.33%
Sep 30, 2018 5.73%
Jun 30, 2018 13.02%
Mar 31, 2018 22.78%
Dec 31, 2017 19.04%
Sep 30, 2017 -4.13%
Jun 30, 2017 -1.44%
Mar 31, 2017 7.07%
Dec 31, 2016 1.83%
Sep 30, 2016 6.21%
Jun 30, 2016 8.82%
Mar 31, 2016 0.45%
Dec 31, 2015 0.89%
Sep 30, 2015 11.59%
Jun 30, 2015 9.27%
Mar 31, 2015 -5.62%
Dec 31, 2014 -7.48%
Sep 30, 2014 -5.31%
Jun 30, 2014 -4.63%
Mar 31, 2014 -19.23%
Dec 31, 2013 -15.16%
Sep 30, 2013 -24.02%
Jun 30, 2013 -27.31%
Mar 31, 2013 -21.22%
Dec 31, 2012 -24.04%
Sep 30, 2012 8.01%
Jun 30, 2012 -2.58%
Mar 31, 2012 -29.65%